文献速递生殖医学

不孕症核心结局指标集在体外受精随机对照试验中的采纳情况评估

Assessing the uptake of infertility core outcome set in IVF randomized controlled trials.
PubMed 文献 · Hum Reprod · 2025-01-01

该横断面研究纳入2004年3月至2024年7月18个注册库中1673项不孕症随机对照试验注册,评估不孕症核心结局指标集(2020年11月30日发布)的采纳情况。结果显示宫内妊娠采纳率最高(66.9%),活产(27.6%)和流产(26.5%)次之,妊娠域报告率显著高于新生儿域(13.6% vs 5.7%)。随时间推移、目标样本量增大及前瞻性注册,注册库报告结局与核心结局指标集的一致性显著改善。

要点

  • 宫内妊娠采纳率最高(66.9%),活产(27.6%)和流产(26.5%)次之,新生儿结局采纳率低。
  • 妊娠域报告率显著高于新生儿域(13.6% vs 5.7%)。
  • 随时间推移、目标样本量增大及前瞻性注册,注册库结局与核心结局指标集一致性显著改善。

核心结论

  • 多数核心结局或域的采纳率在上升但尚不理想,且上升趋势不能仅归因于不孕症核心结局指标集的发布。

研究设计与样本

  • 横断面研究,基于注册库条目纳入2004年3月至2024年7月18个注册库中1673项符合条件的不孕症随机对照试验注册。
  • 从世界卫生组织国际临床试验注册平台检索1999年11月1日至2024年7月26日共4625项不孕症相关研究,最终选取1673项随机对照试验注册并分为四个时期组。

主要发现

  • 妊娠域报告水平显著高于新生儿域(13.6% vs 5.7%)。
  • 宫内妊娠(66.9%)、活产(27.6%)和流产(26.5%)采纳水平相对较高。
  • 多数核心结局和域及报告核心结局总数的采纳情况在时期、目标样本量和前瞻性注册方面显示统计学显著差异。
  • 多变量分析支持上述发现。

临床怎么用

  • 作者认为促进采纳的关键是深入探究并认识促进和阻碍不孕症核心结局指标集采纳的因素,进一步扩大和宣传该核心结局指标集,并促进多学科或多利益相关方合作。

局限性

  • 由于注册库信息的复杂性,本研究部分结果可能受评估者主观判断的影响。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

STUDY QUESTION: Do the infertility core outcome set and standardized definitions affect the outcome selection for randomized controlled trials, and what aspects should be further improved in the future? SUMMARY ANSWER: Intrauterine pregnancy demonstrated the highest uptake level, whereas others were low, especially in neonatal outcomes; as time progresses, the target sample size increases, and with prospective registration, the consistency between outcomes reported in registrations and infertility core outcome set improves significantly. WHAT IS KNOWN ALREADY: The infertility core outcome set, published on 30 November 2020, aims to standardize outcome reporting and prevent selective reporting bias; however, there is a paucity of research evaluating its actual adoption, which is crucial for the timely promotion of transparency, standardization, adjustment of development strategies, and efficient resource utilization. STUDY DESIGN, SIZE, DURATION: This cross-sectional study included 1673 eligible randomized controlled trial registrations for infertility in 18 registries from March 2004 to July 2024 based on registry entries. PARTICIPANTS/MATERIALS, SETTING, METHODS: A total of 4625 infertility-related studies from 1 November 1999 to 26 July 2024 were retrieved in the World Health Organization International Clinical Trials Registry Platform. Finally, 1673 randomized controlled trial registrations were selected and divided into four period groups. Period, target sample size, prospective registration, blinding, support, and countries/regions were potential influencing factors. The consistency of outcomes, definitions, and standardized denominators of randomized controlled trial registry entries with the recommendations of the infertility core outcome set were the main outcomes. Independent retrieval, screening, data extraction, and consistency evaluations by two assessors and expert consultations were conducted to assess the uptake and potential influencing factors of the infertility core outcome set in randomized controlled trials involving infertile patients undergoing in vitro fertilization. MAIN RESULTS AND THE ROLE OF CHANCE: Results reveal that the reporting level in the pregnancy domain was significantly higher than that in the neonatal domain (13.6% vs 5.7%). Intrauterine pregnancy (66.9%), live birth (27.6%), and miscarriage (26.5%) had relatively high uptake levels. The uptake of most core outcomes and domains, as well as the total number of reported core outcomes, showed statistically significant differences based on period, target sample size, and prospective registration. Multivariable analyses supported the above finding. Reasons responsible for the results may be attributed to the lack of effective promotional measures, as well as the limited researcher awareness regarding this core outcome set. LIMITATIONS, REASONS FOR CAUTION: Some results in this study may have been influenced by the subjective judgment of the evaluators due to the complexity of the information in registries. WIDER IMPLICATIONS OF THE FINDINGS: Uptake of most core outcomes or domains is increasing but is not yet ideal. Moreover, the upward trend cannot be solely attributed to the publication of the infertility core outcome set. The key to promoting uptake is to thoroughly explore and recognize the factors that both facilitate and hinder the uptake of the infertility core outcome set, further expand and publicize the core outcome set, and foster multidisciplinary or multiple stakeholder cooperation. STUDY FUNDING/COMPETING INTEREST(S): This study was supported by the Capital's Funds for Health Improvement and Research (CFH 2024-2G-4097), as well as the special fund of Beijing Key Clinical Specialty Construction Project. The authors have no conflicts of interest to declare. TRIAL REGISTRATION NUMBER: http://www.comet-initiative.org/Studies/Details/3184.

来源:Hum Reprod,查看原文。版权归原作者所有。

引用

  1. Li W, Jia N, Chi H, et al. Assessing the uptake of infertility core outcome set in IVF randomized controlled trials. Hum Reprod. 2025. PMID: 39673431. doi:10.1093/humrep/deae255

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。